Cytoplasmic Dynein Antagonists with Improved Potency and Isoform Selectivity.

TitleCytoplasmic Dynein Antagonists with Improved Potency and Isoform Selectivity.
Publication TypeJournal Article
Year of Publication2016
AuthorsSee SK, Hoogendoorn S, Chung AH, Ye F, Steinman JB, Sakata-Kato T, Miller RM, Cupido T, Zalyte R, Carter AP, Nachury MV, Kapoor TM, Chen JK
JournalACS Chem Biol
Volume11
Issue1
Pagination53-60
Date Published2016 Jan 15
ISSN1554-8937
KeywordsAnimals, Cytoplasmic Dyneins, Hedgehog Proteins, Mice, Molecular Structure, NIH 3T3 Cells, Protein Isoforms, Quinazolinones, Signal Transduction, Structure-Activity Relationship, Substrate Specificity
Abstract

Cytoplasmic dyneins 1 and 2 are related members of the AAA+ superfamily (ATPases associated with diverse cellular activities) that function as the predominant minus-end-directed microtubule motors in eukaryotic cells. Dynein 1 controls mitotic spindle assembly, organelle movement, axonal transport, and other cytosolic, microtubule-guided processes, whereas dynein 2 mediates retrograde trafficking within motile and primary cilia. Small-molecule inhibitors are important tools for investigating motor protein-dependent mechanisms, and ciliobrevins were recently discovered as the first dynein-specific chemical antagonists. Here, we demonstrate that ciliobrevins directly target the heavy chains of both dynein isoforms and explore the structure-activity landscape of these inhibitors in vitro and in cells. In addition to identifying chemical motifs that are essential for dynein blockade, we have discovered analogs with increased potency and dynein 2 selectivity. These antagonists effectively disrupt Hedgehog signaling, intraflagellar transport, and ciliogenesis, making them useful probes of these and other cytoplasmic dynein 2-dependent cellular processes.

DOI10.1021/acschembio.5b00895
Alternate JournalACS Chem. Biol.
PubMed ID26555042
PubMed Central IDPMC4715766
Grant List100387 / / Wellcome Trust / United Kingdom
MC_UP_A025_1011 / / Medical Research Council / United Kingdom
R01 GM098579 / GM / NIGMS NIH HHS / United States
R01 CA136574 / CA / NCI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
R01 GM089933 / GM / NIGMS NIH HHS / United States

Person Type: